Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 4, 2021
Is cytology/HPV co-testing for cervical cancer screening useful in Japan?Tetsuro Oishi, Junzo Kigawa, Osamu Iwanari, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 5, 2011
Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study GroupSohei Yamamoto, Atsuko Kasajima, Masashi Takano, et al.
British Journal of Cancer|February 1, 2020
A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancerKosei Hasegawa, Muneaki Shimada, Satoshi Takeuchi, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|November 20, 2018
Liquid-based endometrial cytology using SurePath™ is not inferior to suction endometrial tissue biopsy for detecting endometrial malignancies: Midterm report of a multicentre study advocated by Japan Association of Obstetricians and GynecologistsYasuo Hirai, Kimihiko Sakamoto, Hiroyuki Fujiwara, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinomaHiroyuki Fujiwara, Harushige Yokota, Bradley Monk, et al.
Heliyon|June 27, 2022
Neutrophil extracellular traps (NETs) reduce the diffusion of doxorubicin which may attenuate its ability to induce apoptosis of ovarian cancer cellsKohei Tamura, Hideyo Miyato, Rihito Kanamaru, et al.
Cellular Immunology|January 13, 2023
Activated neutrophils inhibit chemotactic migration of activated T lymphocytes to CXCL11 by multiple mechanismsKohei Tamura, Hideyo Miyato, Rihito Kanamaru, et al.
Cancer Science|June 3, 2009
Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosisKosuke Yoshihara, Atsushi Tajima, Dai Komata, et al.
Archives of Public Health = Archives Belges De Sante Publique|February 27, 2015
Effect of providing risk information on undergoing cervical cancer screening: a randomized controlled trialHiroyuki Fujiwara, Akihiro Shimoda, Yoshiki Ishikawa, et al.
International Journal of Clinical Oncology|May 20, 2024
Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex modelsReika Kawabata-Iwakawa, Norihiro Iwasa, Kenichi Satoh, et al.
Pageof 18